Carvacrol attenuates histopathogic and functional impairments induced by bilateral renal ischemia/reperfusion in rats

These results suggest that CARV treatment could reduce renal injury induced by bilateral renal I/R via anti-inflammatory, antioxidant and cytoprotective effects.